7 enrolling by invitation. 7 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 7 | Enrolling by invitation 7 |
Follow Neurocognitive Disorders: new trials by email Literature Review of Neurocognitive Disorders trials Research Report on Neurocognitive Disorders
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Pilot Study of StudyU for N-of-1 Trials in HFrEF Patients (N-of-1 App) beta blockers, StudyU Application - HFrEF - Heart Failure With Reduced Ejection Fraction, Heart Failure | Phase 4 | Enrolling by invitation | Weill Medical College of Cornell University | 5 | 2026-02-10 | 2026-02-19 |
| Effects of Ciprofol on Perioperative Neurocognitive Function in Elderly Patients Undergoing Daytime Surgery Ciprofol, propofol - PND, POCD - Postoperative Cognitive Dysfunction | Phase 4 | Enrolling by invitation | Second Affiliated Hospital of Wenzhou Medical University | 148 | 2025-04-25 | 2026-10-26 |
| MIBG in Aging and Neurologic Disorders meta-iodobenzylguanidine (MIBG) (123I), 123I-MIBG scintigraphy - Lewy Body Disease, Dementia | Phase 4 | Enrolling by invitation | Mayo Clinic | 50 | 2023-05-08 | 2026-07-30 |
| Longitudinal Imaging Biomarkers of Disease Progression in DLB 18F-Flortaucipir - Lewy Body Disease | Phase 4 | Enrolling by invitation | Kejal Kantarci | 135 | 2018-06-25 | 2026-03-19 |
| Quality Improvement and Practice Based Research in Neurology Using the EMR Listed for each disorder below, up to three drugs per disorder (too many characters to list in this field; see Intervention Description) - Brain Tumors, Epilepsy | Phase 4 | Enrolling by invitation | Endeavor Health | 3300 | 2016-05-01 | 2025-08-24 |
| DaTSCAN Imaging in Aging and Neurodegenerative Disease I-123 Ioflupane solution injection prior to SPECT scan (DaTscan), Single photon emission computed tomography (SPECT) scan - Dementia, Parkinsonism | Phase 4 | Enrolling by invitation | Mayo Clinic | 500 | 2011-10-01 | 2026-03-10 |
| Imaging of Brain Amyloid Plaques in the Aging Population Pittsburgh Compound B (C-11 PiB), F-18 FDG, Tau (18-F-AV-1451) - Alzheimer's Disease, Dementia With Lewy Bodies | Phase 4 | Enrolling by invitation | Mayo Clinic | 8000 | 2008-04-01 | 2026-06-23 |
Cognitive Dysfunction (3) · Dementia (3) · Lewy Body Disease (3) · Alzheimer Disease (2) · Parkinsonian Disorders (2) · REM Sleep Behavior Disorder (2) · Brain Concussion (1) · Brain Neoplasms (1) · Dementia, Vascular (1) · Epilepsy (1) · Frontotemporal Dementia (1) · Heart Diseases (1) · Heart Failure (1) · Heart Failure, Systolic (1) · Migraine Disorders (1)
Mental Disorders (7) · Brain Diseases (6) · Central Nervous System Diseases (6) · Nervous System Diseases (6) · Basal Ganglia Diseases (5) · Movement Disorders (5) · Neurodegenerative Diseases (5) · Cognition Disorders (4) · Synucleinopathies (4) · Cardiovascular Diseases (3) · Parasomnias (3) · Parkinsonian Disorders (3) · Sleep Wake Disorders (3) · Cerebrovascular Disorders (2)
2-(4'-(methylamino)phenyl)-6-hydroxybenzothiazole (2) · (2-(1R)-1-cyclopropyl)ethyl-6-isopropyl-phenol (1) · 3-Iodobenzylguanidine (1) · 7-(6-fluoropyridin-3-yl)-5H-pyrido(4,3-b)indole (1) · Adrenergic beta-Antagonists (1) · Iodine-123 (1) · Propofol (1) · Radionuclide Imaging (1) · Tomography, Emission-Computed, Single-Photon (1) · ioflupane (1) · tau Proteins (1)
Mayo Clinic (3) · Endeavor Health (1) · Kejal Kantarci (1) · Second Affiliated Hospital of Wenzhou Medical University (1) · Weill Medical College of Cornell University (1)
United States (6) · China (1)
Bradley Boeve, MD (2) · Kejal Kantarci, MD (1) · Parag Goyal, MD, MSc (1) · Val Lowe, M.D. (1)
PMID 29560382, PMID 32198310, PMID 33348363, PMID 33408148, PMID 33422890, PMID 36844148
R01AG011378 (1), U01AG006786 (1), U01NS100620 (1)